9 METERS BIOPHARMA, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 2012-01-01
- Employees
- 10
- Market Cap
- -
- Website
- http://9meters.com
Clinical Trials
10
Active:0
Completed:7
Trial Phases
3 Phases
Phase 1:3
Phase 2:6
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials
Phase 2
6 (60.0%)Phase 1
3 (30.0%)Phase 3
1 (10.0%)VIBRANT Study of Vurolenatide in Adult Patients With Short Bowel Syndrome.
Phase 2
Terminated
- Conditions
- Short Bowel Syndrome
- Interventions
- First Posted Date
- 2021-08-04
- Last Posted Date
- 2022-12-20
- Lead Sponsor
- 9 Meters Biopharma, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04988997
- Locations
- 🇺🇸
Research Site, Nashville, Tennessee, United States
Proof of Concept Study in Patients With Short Bowel Syndrome
- First Posted Date
- 2020-05-08
- Last Posted Date
- 2020-11-20
- Lead Sponsor
- 9 Meters Biopharma, Inc.
- Target Recruit Count
- 12
- Registration Number
- NCT04379856
- Locations
- 🇺🇸
Research Facility One, Los Angeles, California, United States
Study to Evaluate the Efficacy and Safety of Larazotide Acetate for the Relief of CeD Symptoms
- First Posted Date
- 2018-06-26
- Last Posted Date
- 2022-07-26
- Lead Sponsor
- 9 Meters Biopharma, Inc.
- Target Recruit Count
- 307
- Registration Number
- NCT03569007
- Locations
- 🇺🇸
Research Site, Wauwatosa, Wisconsin, United States
A Double-blind Placebo-controlled Study to Evaluate Larazotide Acetate for the Treatment of Celiac Disease
- First Posted Date
- 2011-07-18
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- 9 Meters Biopharma, Inc.
- Target Recruit Count
- 342
- Registration Number
- NCT01396213
Study of the Efficacy of Larazotide Acetate to Treat Celiac Disease
Phase 2
Completed
- Conditions
- Celiac Disease
- Interventions
- First Posted Date
- 2009-04-29
- Last Posted Date
- 2017-09-20
- Lead Sponsor
- 9 Meters Biopharma, Inc.
- Target Recruit Count
- 42
- Registration Number
- NCT00889473
- Locations
- 🇨🇦
Study Site, Edmonton, Alberta, Canada
- Prev
- 1
- 2
- Next
News
No news found